Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03283943
Title PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
Recruitment Unknown status
Gender female
Phase Phase I
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

ovarian cancer

fallopian tube cancer

peritoneum cancer

Therapies

Durvalumab

Age Groups:
Covered Countries CAN


No variant requirements are available.